摘要
头颈部鳞状细胞癌(HNSCC)是世界上排名第六的最常见的癌症,在过去几十年间,其生存率并没有得到改善。目前的治疗手段包括手术、放射治疗和化疗,但是这些治疗手段对于复发或转移性肿瘤来说都是相对无效的。因此,寻找一种专门针对顽固HNSCC肿瘤干细胞(CSCs)的新型治疗手段迫在眉睫,CSCs是引起肿瘤初发和转移的族群。鉴于其对基因表达和生物进程的巨大影响,包括干细胞功能,非编码RNAs已经成为一种有前景的作为潜在的诊断和治疗靶点的基因研究的新课题。这篇综述对当前的调查研究进行了一个综合的概述,其将有助于我们了解在ncRNA和HNSCC肿瘤干细胞的生物学间的仍然停留在试验阶段的联系。我们这样做的目的是分析干细胞在HNSCC分子靶向癌症治疗的发展过程中的潜在的与干细胞相关的ncRNAs的作用。尽管大多数关于HNSCC和ncRNAD的现代化的知识主要集中于微小核糖核酸,我们仍然选择给予ncRNAs的其他种类(lncRNA、piRNA和 snoRNA)相当的关注,这些其他种类中的许多尚未被很好的了解或还没有被发现,从而代表了在HNSCC治疗中分子靶点或者生物标记的一个潜在的令人兴奋的而尚未被开发的宝库。
关键词: 肿瘤干细胞,头颈部鳞状细胞癌(HNSCC)
Current Drug Targets
Title:Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells
Volume: 15 Issue: 13
Author(s): Elham Rahimy, Selena Z. Kuo and Weg M. Ongkeko
Affiliation:
关键词: 肿瘤干细胞,头颈部鳞状细胞癌(HNSCC)
摘要: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world and has not seen improved survival rates over the past few decades. Current treatment plans include surgery, radiation therapy, and chemotherapy, but these are relatively ineffective options for recurrent or metastatic tumors. Therefore, there is a high priority for new therapies that specifically target the resistant HNSCC cancer stem cells (CSCs), a subpopulation responsible for tumor initiation and metastasis. Given their vast effects on gene expression and biological processes, including stem cell capabilities, non-coding RNAs (ncRNAs) have become a promising new repertoire of genes to investigate as potential diagnostic or therapeutic targets. This review presents a comprehensive overview of current investigative studies that can contribute to our understanding of the still tentative link between ncRNA and the biology of HNSCC cancer stem cells. In doing so, we aim to analyze the potential role of stem cell-related ncRNAs in the development of molecularly targeted cancer therapy for HNSCC. Although the majority of updated knowledge on HNSCC and ncRNA focuses heavily on microRNA, we chose to give considerable attention to the promise of other classes of ncRNAs (lncRNA, piRNA, and snoRNA), many of which are not yet well characterized or are yet to be discovered, and thus represent a potentially exciting and untapped pool of molecular targets or biomarkers in HNSCC therapy.
Export Options
About this article
Cite this article as:
Elham Rahimy, Selena Z. Kuo and Ongkeko M. Weg, Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells, Current Drug Targets 2014; 15 (13) . https://dx.doi.org/10.2174/1389450115666141024113446
DOI https://dx.doi.org/10.2174/1389450115666141024113446 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Typical and Atypical Imaging Findings of Abdominal Teratomas
Current Medical Imaging PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance
Current Cancer Drug Targets Clinical Applications of <sup>18</sup>F-FDG PET/CT in Monitoring Anti-cancer Therapies
Current Pharmaceutical Biotechnology Computational Approach to the Discovery of Phytochemical Molecules with Therapeutic Potential Targets to the PKCZ protein
Letters in Drug Design & Discovery Expression of NRP-1 and NRP-2 in Endometrial Cancer
Current Pharmaceutical Biotechnology Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery
Current Drug Targets Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Challenges and Opportunities in Molecular Imaging
Current Medical Imaging From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension
Current Vascular Pharmacology NF-κB Links Keratinocytes and Lymphocytes in the Pathogenesis of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review
Current Drug Targets Allelic Variations in 5, 10-Methylenetetrahydrofolate Reductase Gene and Susceptibility to Cervical Cancer in Indian Women
Drug Metabolism Letters The Potential Anti-Tumorigenic and Anti-Metastatic Side of the Proprotein Convertases Inhibitors
Recent Patents on Anti-Cancer Drug Discovery MicroRNAs as Cancer Biomarkers
MicroRNA The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers
Current Medicinal Chemistry Costimulation, Coinhibition and Cancer
Current Cancer Drug Targets